Kaplan, AlanHeatley, HeathTownend, JohnSkinner, DerekCarter, VictoriaHubbard, RichardTan, Tze LeeKoh, Mariko SiyuePrice, David2025-06-182025-06-182025-06Kaplan, A, Heatley, H, Townend, J, Skinner, D, Carter, V, Hubbard, R, Tan, T L, Koh, M S & Price, D 2025, 'The real-world impact of Glucagon-like peptide 1 receptor agonists on asthma control in people with high risk asthma and obesity', Advances in Therapy, vol. 42, pp. 2950–2956. https://doi.org/10.1007/s12325-025-03175-x0741-238Xhttps://hdl.handle.net/2164/255837253316engSDG 3 - Good Health and Well-beingAsthmaObesityAsthma outcomesGLP1sR Medicine (General)Supplementary DataDASLinkR1The real-world impact of Glucagon-like peptide 1 receptor agonists on asthma control in people with high risk asthma and obesityJournal article10.1007/s12325-025-03175-x42